ICH-GCP E6 (R2)

Good Clinical Practice (GCP) is an international ethical and scientific quality standard for designing, conducting, recording and reporting trials that involve the participation of human subjects. The ICH GCP Guideline was developed with consideration of the current good clinical practices of the European Union, Japan, and the United States, as well as those of Australia, Canada, the Nordic countries and the World Health Organization (WHO). This guideline should be followed when generating clinical trial data that are intended to be submitted to regulatory authorities.

Since the development of the ICH GCP Guideline, the scale, complexity, and cost of clinical trials have increased. The guideline was amended to E6(R2) in 2016 to encourage implementation of improved and more efficient approaches to clinical trial design, conduct, oversight, recording and reporting while continuing to ensure human subject protection and reliability of trial results.

The current version of ICH-GCP E6 (R2) guideline can be found here.